Plavix®, marketed by Bristol-Myers Squibb and Sanofi Pharmaceuticals, is the second most commonly prescribed drug on the U.S. market to prevent heart attacks and stroke. The medication, known as a “clopidogrel,” is a blood thinner that belongs to a category of drugs called antiplatelets. The drug works to prevent blood clots.
A recent study by the Neurological Disorders and Stroke (NINDS) concludes that Plavix® offers no further benefits than other competing antiplatelet medications and may actually increase the risk of suffering a heart attack or stroke. Previous studies have discussed the harm of this common combination of Plavix® and aspirin.
As we have previously reported, Plavix® litigation continues to proceed in New Jersey State and Federal courts. If you feel you have experienced any side-effects from taking Plavix®, you can contact Stark & Stark and speak to one of the Mass Tort/Pharmaceutical Litigation attorneys, free of charge, who can help assess any claims that you might have against the Plavix® manufacturers.